Stepan (NYSE: SCL) VP Eaken reports direct and ESOP-held share ownership
Rhea-AI Filing Summary
Stepan Company VP, Controller & PAO Matthew John Eaken filed an initial statement of beneficial ownership reporting 9,319 shares of Stepan common stock held directly and 3,102 shares held indirectly through an ESOP II Trust. He also reports a portfolio of stock options and stock appreciation rights on Stepan common stock with exercise prices between $50.06 and $123.73, plus performance share and restricted stock unit awards, each representing contingent rights to receive Stepan common shares based on vesting schedules or performance goals.
Positive
- None.
Negative
- None.
Insider Trade Summary
26 transactions reported
Mixed
26 txns
Insider
Eaken Matthew John
Role
VP, Controller & PAO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) F1 | -- | -- | -- |
| holding | Stock Appreciation Right F1 | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Performance Shares F3, F2 | -- | -- | -- |
| holding | Stock Appreciation Right | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Performance Shares F3, F4 | -- | -- | -- |
| holding | Stock Appreciation Right | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Performance Shares F3, F5 | -- | -- | -- |
| holding | Stock Appreciation Right | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Appreciation Right | -- | -- | -- |
| holding | Performance Shares F3, F6 | -- | -- | -- |
| holding | Stock Appreciation Right F1 | -- | -- | -- |
| holding | Stock Appreciation Right F1 | -- | -- | -- |
| holding | Restricted Stock Units F7, F1 | -- | -- | -- |
| holding | Stock Appreciation Right F1 | -- | -- | -- |
| holding | Performance Shares F3, F8 | -- | -- | -- |
| holding | Restricted Stock Units F9, F1 | -- | -- | -- |
| holding | Stock Appreciation Right F1 | -- | -- | -- |
| holding | Performance Shares F3, F10 | -- | -- | -- |
| holding | Restricted Stock Units F9, F1 | -- | -- | -- |
| holding | Stock Appreciation Right F1 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 3,435 shares (Direct);
Stock Appreciation Right — 16,500 shares (Direct);
Performance Shares — 3,539 shares (Direct);
Restricted Stock Units — 2,064 shares (Direct);
Common Stock — 9,319 shares (Direct);
Common Stock — 3,102 shares (Indirect, By ESOP II Trust)
Footnotes (10)
- F1. Vests ratably over three years beginning on the date shown.
- F2. Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021.
- F3. Each performance share represents a contingent right to receive one share of Stepan Company common stock.
- F4. Each performance share represents a contingent right to receive one share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2020.
- F5. Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2022.
- F6. Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2024.
- F7. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock.
- F8. The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2027.
- F9. Each RSU represents a contingent right to receive one share of Stepan Company common stock.
- F10. The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028.
Key Figures
Direct common shares: 9,319 shares
Indirect common shares: 3,102 shares
SAR at $50.06: 1,789 shares
+3 more
6 metrics
Direct common shares
9,319 shares
Common Stock held directly as of the reporting date
Indirect common shares
3,102 shares
Common Stock held indirectly "By ESOP II Trust"
SAR at $50.06
1,789 shares
Underlying shares for Stock Appreciation Right at $50.0600 expiring 2036-03-02
SAR at $59.86
1,474 shares
Underlying shares for Stock Appreciation Right at $59.8600 expiring 2035-03-03
Highest option exercise price
$123.7300
Stock Option (Right to Buy) on 514 underlying shares expiring 2031-02-16
RSU grant expiring 2029-03-02
1,249 units
Restricted Stock Units, each representing a contingent right to one Stepan common share
Key Terms
Stock Appreciation Right, Performance Shares, Restricted Stock Units, ESOP II Trust
4 terms
Stock Appreciation Right financial
"security_title: Stock Appreciation Right on Stepan common stock"
A stock appreciation right (SAR) is a form of employee pay that gives the holder the right to receive the increase in a company's share price over a set reference price, paid in cash or shares, without having to buy stock first. It matters to investors because SARs can create future cash outflows or dilute existing shareholders if settled in stock, and they align employee incentives with share-price performance like a bonus tied to a home's price rise.
Restricted Stock Units financial
"security_title: Restricted Stock Units representing rights to Stepan shares"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
ESOP II Trust financial
"nature_of_ownership: By ESOP II Trust for indirect common stock holdings"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
Who is the insider in Stepan (SCL)'s Form 3 and what is his role?
The insider is Matthew John Eaken, who serves as Stepan Company’s VP, Controller & Principal Accounting Officer. The Form 3 records his initial beneficial ownership of Stepan equity, including common shares and various equity-based incentive awards.
What stock options and stock appreciation rights does Eaken hold in Stepan (SCL)?
Eaken lists multiple stock options and stock appreciation rights on Stepan common stock, with exercise prices ranging from $50.06 to $123.73 and expiration dates running from 2027 through 2036, each tied to specified numbers of underlying shares.
Which restricted stock units (RSUs) are included in Eaken’s Stepan (SCL) holdings?
The filing includes restricted stock units where each RSU represents a contingent right to receive one Stepan common share, including blocks of 119, 696, and 1,249 RSUs with vesting schedules spanning from 2025 through 2029, subject to time-based conditions.